2 nearly penny stocks to buy in September

I’m on a quest to find some of the best cheap UK stocks to buy. Here are a couple of former penny stocks I’d happily buy in September.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

A lot of UK share investors don’t like to buy cheap companies like penny stocks. Their low cost means that this type of stock is often bought and sold in huge volumes, something that can cause significant price volatility.

I buy stocks for the long term, though. And so the prospect of temporary share price choppiness doesn’t put me off from buying low-cost shares. Here are a couple of top nearly penny stocks I think could soar in value in the years ahead.

The right medicine

The Alliance Pharma (LSE: APH) has risen an impressive 50% during the past 12 months. And in recent sessions this former penny stock has barged to record highs above £1. I reckon the business could gain further traction too when half-year results are unveiled on Tuesday, 21 September.

Alliance Pharma owns the marketing rights to scores of heavyweight brands in the fields of consumer healthcare and prescription medicine. These products, like Kelo-Cote scar treatment, Nizoral dandruff shampoo, and (following recent acquisition action) menopause reliever Amberen, sell in huge quantities in more than 100 countries. Indeed, latest financials showed like-for-like sales of its health products up 8% in the six months to June.

Its successful M&A-led growth strategy has helped Alliance Pharma’s earnings rise 33% over the past five years. So I’m encouraged that the stock has plenty of appetite and financial clout to keep going. But acquisitions are risky business and past form is not always a reliable guide to future performance. Revenues from acquisitions can disappoint and costs can swell, taking a big bite out of profits.

A dirt-cheap penny stock I’d buy today

It’s clear that housebuilding activity in the UK needs to ratchet up several gears over the next decade. And this bodes well for manufacturers of building products like Michelmersh Brick Holdings (LSE: MBH). I’ve already bought brickmaker Ibstock for my Stocks and Shares ISA for the very same reason.

I’d buy this nearly penny stock before it releases half-year results on Tuesday, 7 September. Most recent financials in June revealed “strong demand” for its products amid a “very active” construction sector. Many major housebuilders are ramping up production as favourable lending conditions supercharge demand for first-time buyers. So I expect trading at Michelmersh to remain quite robust for some time to come, a theme I don’t think is reflected at current prices. Today the low-cost share trades around 136p, resulting in a forward price-to-earnings growth (PEG) ratio of just 0.5.

I think Michelmersh is a top buy despite the impact that an economic downturn could have on its top line. The UK economy has bounced back strongly following 2020’s Covid-19-related washout. But the rebound could prove temporary and home sales could falter if the Delta variant continues spreading aggressively.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild owns shares of Ibstock. The Motley Fool UK has recommended Alliance Pharma and Ibstock. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »